amphetamine

FDA Drug Profile — Dyanavel XR, DYANAVEL XR

amphetamine is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand names including Dyanavel XR, DYANAVEL XR. Available dosage forms: suspension, extended release, tablet, extended release.

Drug details

Generic Name
amphetamine
Brand Names
Dyanavel XR, DYANAVEL XR
Application Number
NDA208147
Sponsor
NextWave Pharmaceuticals, Inc
NDC Codes
5
Dosage Forms
SUSPENSION, EXTENDED RELEASE, TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients
AMPHETAMINE

Indications and Usage

1 INDICATIONS AND USAGE DYANAVEL XR is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [see Clinical Studies (14) ]. Limitations of Use The use of DYANAVEL XR is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.5) , Use in Specific Populations (8.4) ]. DYANAVEL XR is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older ( 1 ) Limitations of Use The use of DYANAVEL XR is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage ( 5.5 , 8.4 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.